UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q2 2021 | 2022-09-01 | 0.00 | 0.00 |
| Q1 2021 | 2022-06-09 | 0.00 | 0.00 |
| Q4 2020 | 2022-03-17 | 0.00 | 0.00 |
| Q3 2020 | 2021-11-19 | 0.00 | 0.00 |
| Q2 2020 | 2021-08-23 | 0.00 | 0.00 |
| Q1 2020 | 2021-06-03 | 0.00 | 0.00 |
| Q4 2019 | 2021-03-16 | 0.00 | 0.00 |
| Q3 2019 | 2019-11-19 | 0.30 | 0.00 |
| Q2 2019 | 2019-08-28 | -0.96 | -0.20 |
| Q1 2019 | 2019-05-23 | -0.75 | -0.18 |
| 2016-05-20 | Initiated Coverage | Deutsche Bank | Buy | $11.00 |
| 2016-05-20 | Initiated Coverage | Deutsche Bank AG | Buy | $11.00 |
| 2016-04-26 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $18.00 to $14.00 |
| 2016-03-13 | Reiterated Rating | Summit Research | Buy to Buy | $22.00 |
| 2015-12-08 | Upgrade | Morgan Stanley | Equal Weight to Overweight | $15.00 to $18.00 |
| 2015-11-09 | Reiterated Rating | Summit Research | Buy | $22.00 |
| 2015-10-27 | Reiterated Rating | Goldman Sachs | Neutral | |
| 2015-10-27 | Reiterated Rating | Goldman Sachs Group Inc. | Neutral | |
| 2015-05-26 | Downgrade | Credit Suisse | Outperform to Neutral | $18.00 to $20.00 |
| 2015-05-26 | Downgrade | Credit Suisse Group AG | Outperform to Neutral | $18.00 to $20.00 |
| 2015-04-20 | Initiated Coverage | Summit Research | Buy | $17.00 |
| 2015-03-05 | Reiterated Rating | Oppenheimer | Hold | |
| 2015-03-05 | Reiterated Rating | Oppenheimer Holdings Inc. | Hold | |
| 2015-02-04 | Upgrade | Morgan Stanley | Equal Weight to Overweight | |
| 2015-01-07 | Upgrade | Credit Suisse | Buy | |
| 2014-08-13 | Downgrade | Credit Suisse | Outperform to Neutral | $20.00 to $18.00 |
| 2014-06-18 | Initiated Coverage | Morgan Stanley | Equal Weight | $19.50 |
| 2014-06-12 | Initiated Coverage | Oppenheimer | Market Perform |
| 2016-05-20 | Initiated Coverage | Deutsche Bank | Buy | $11.00 |
| 2016-05-20 | Initiated Coverage | Deutsche Bank AG | Buy | $11.00 |
| 2016-04-26 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $18.00 to $14.00 |
| 2016-03-13 | Reiterated Rating | Summit Research | Buy to Buy | $22.00 |
| 2015-12-08 | Upgrade | Morgan Stanley | Equal Weight to Overweight | $15.00 to $18.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In TOUR 22 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| MORGAN STANLEY | 4.51M |
| UBS Group AG | 2.75M |
| GOLDMAN SACHS GROUP INC | 1.45M |
| SC CHINA HOLDING Ltd | 1.11M |
| HERMES INVESTMENT MANAGEMENT LTD | 0.54M |
| BANK OF AMERICA CORP /DE/ | 0.50M |
| DIMENSIONAL FUND ADVISORS LP | 0.35M |
| RENAISSANCE TECHNOLOGIES LLC | 0.29M |
| CANTOR FITZGERALD, L. P. | 0.24M |
| BlackRock Fund Advisors | 0.20M |
| BlackRock Institutional Trust Company, N.A. | 0.18M |
| MARSHALL WACE ASIA Ltd | 75962 |
| BlackRock Group LTD | 56845 |
| Index Management Solutions, LLC | 35620 |
| Virtu Financial LLC | 31458 |
UM